Evolution of laboratory values in patients with Kawasaki disease

Adriana H Tremoulet1, Sonia Jain, Divya Chandrasekar

  • 1Department of Pediatrics, University of California, San Diego and Rady Children's Hospital San Diego, La Jolla, CA 92093, USA. atremoulet@ucsd.edu

Insights

Kawasaki disease (KD) laboratory values change predictably during illness and after intravenous immunoglobulin (IVIG) treatment. Tracking these dynamic changes aids in diagnosing KD and assessing coronary artery outcomes.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Clinical Pathology

Background:

  • Diagnosis of Kawasaki disease (KD) relies on clinical laboratory studies per American Heart Association guidelines.
  • Detailed evolution of laboratory values during KD illness has not been previously reported.

Purpose of the Study:

  • To characterize the evolution of clinical laboratory values in KD patients before and after intravenous immunoglobulin (IVIG) treatment.
  • To correlate laboratory value changes with treatment response and coronary artery outcomes.

Main Methods:

  • Analysis of laboratory values from 380 KD patients at acute, subacute, and convalescent phases.
  • Stratification of results by IVIG response and coronary artery outcome.

Main Results:

  • White blood cell count, ESR, and CRP peaked in the acute phase; platelet count peaked in the subacute phase; lymphocytes and eosinophils peaked in the convalescent phase.
  • Patients with coronary artery aneurysms showed higher WBC in the subacute phase and higher ESR in subacute and convalescent phases.

Conclusions:

  • Consistent evolution of laboratory values is observed in KD before and after treatment.
  • Understanding dynamic laboratory changes aids physicians in diagnosing KD using American Heart Association guidelines.
Abstract

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...